Clinical Trial Update: CD133+ Autologous Cells After Myocardial Infarction [Phase 1, Phase 2]

View source ↗

Summary

This document provides an update on a Phase 1/2 trial evaluating CD133+ autologous cell therapy after acute myocardial infarction. The trial status is completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• CD133+ Autologous Cells (CD133+ autologous cells)

Snippet

Sponsor: Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | Conditions: Acute Myocardial Infarction | Phase 1, Phase 2 | Status: COMPLETED